|
ME2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.264370E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.093670E-02 |
| Normal-vs-Stage2 |
2.758200E-01 |
| Normal-vs-Stage3 |
9.754600E-01 |
| Normal-vs-Stage4 |
8.101200E-01 |
| Stage1-vs-Stage2 |
2.355600E-02 |
| Stage1-vs-Stage3 |
1.412400E-01 |
| Stage1-vs-Stage4 |
2.244200E-01 |
| Stage2-vs-Stage3 |
4.391800E-01 |
| Stage2-vs-Stage4 |
7.000200E-01 |
| Stage3-vs-Stage4 |
8.354000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.592300E-02 |
| Normal-vs-AfricanAmerican |
8.867600E-01 |
| Normal-vs-Asian |
8.391800E-01 |
| Caucasian-vs-AfricanAmerican |
2.130200E-01 |
| Caucasian-vs-Asian |
4.731400E-01 |
| AfricanAmerican-vs-Asian |
8.070000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.398200E-03 |
| Normal-vs-Female |
1.247640E-01 |
| Male-vs-Female |
5.997900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.787600E-01 |
| Normal-vs-Extreme_Weight |
6.184800E-04 |
| Normal-vs-Obese |
5.481200E-01 |
| Normal-vs-Extreme_Obese |
6.103400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.061600E-02 |
| Normal_Weight-vs-Obese |
8.391200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.216000E-01 |
| Extreme_Weight-vs-Obese |
4.677800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.025800E-01 |
| Obese-vs-Extreme_Obese |
8.010000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.729800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.382400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.134300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.258600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.238200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.426230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.500240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.917600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.851600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.193400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.556000E-03 |
| Normal-VS-Type2 PRCC |
9.656800E-01 |
| Normal-VS-KIRP CIMP |
4.079500E-03 |
| Normal-VS-Unclassified PRCC |
7.948400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.133900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.59270000000112E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.356100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.480800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.128000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.735100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.097400E-01 |
| Normal-vs-N1 |
2.410000E-01 |
| Normal-vs-N2 |
8.527000E-01 |
| N0-vs-N1 |
7.228100E-02 |
| N0-vs-N2 |
8.922200E-01 |
| N1-vs-N2 |
4.828400E-01 |
|
|
